Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies

Objective: To address the relationship between dementia and neuropathologic findings in dementia with Lewy bodies (DLB) in comparison with AD. Methods: We evaluated the clinical presentation of autopsy-confirmed DLB in comparison with AD according to new Consortium on DLB criteria and compared the two conditions using quantitative neuropathologic techniques. This clinicopathologic series included 81 individuals with AD, 20 with DLB (7 “pure” DLB and 13 “DLB/AD”), and 33 controls. We counted number of LB, neurons, senile plaques (SP), and neurofibrillary tangles (NFT) in a high order association cortex, the superior temporal sulcus (STS), using stereologic counting techniques. Results: The sensitivity and specificity of Consortium on DLB clinical criteria in this series for dementia, hallucinations, and parkinsonism are 53% and 83%, respectively, at the patient’s initial visit and 90% and 68%, respectively, if data from all clinic visits are considered. In pathologically confirmed DLB brains, LB formation in an association cortical area does not significantly correlate with duration of illness, neuronal loss, or concomitant AD-type pathology. Unlike AD, there is no significant neuronal loss in the STS of DLB brains unless there is concomitant AD pathology (neuritic SP and NFT). Conclusions: The evaluation of new Consortium on DLB criteria in this series highlights their utility and applicability in clinicopathologic studies but suggests that sensitivity and specificity, especially at the time of the first clinical evaluation, are modest. The lack of a relationship of LB formation to the amount of Alzheimer-type changes in this series suggests that DLB is a distinct pathology rather than a variant of AD.

[1]  C. Hofstetter,et al.  Dementia with Lewy Bodies Versus Pure Alzheimer Disease: Differences in Cognition, Neuropathology, Cholinergic Dysfunction, and Synapse Density , 1997, Journal of neuropathology and experimental neurology.

[2]  P. Ince,et al.  A quantitative comparison of plaque types in Alzheimer’s disease and senile dementia of the Lewy body type , 1996, Acta Neuropathologica.

[3]  L. Hansen,et al.  Criteria for Alzheimer's Disease and the Nosology of Dementia with Lewy Bodies , 1997, Neurology.

[4]  P. Ince,et al.  Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.

[5]  Robert H. Perry,et al.  Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.

[6]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[7]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  S. Corkin,et al.  Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. , 1995, Archives of neurology.

[9]  D. Irving,et al.  Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei , 1990, Journal of the Neurological Sciences.

[10]  Z. Khachaturian Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[11]  J. Polak,et al.  Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type , 1992, Neuroscience Letters.

[12]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[13]  L. Wolfson,et al.  Clinico‐pathologic studies in dementia , 1988, Neurology.

[14]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[15]  E. Masliah,et al.  Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.

[16]  Kevin Cox,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex , 1990, The Journal of comparative neurology.

[17]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[18]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[19]  M. Sliwinski,et al.  Pathological markers associated with normal aging and dementia in the elderly , 1993, Annals of neurology.

[20]  R. Godwin-Austen,et al.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[21]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[22]  Michael Alford,et al.  Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies , 1993, Brain Research.

[23]  D. Galasko,et al.  Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.

[24]  W. Honer,et al.  Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease , 1994, Brain Research.

[25]  Richard Hollister,et al.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.

[26]  D. Galasko,et al.  Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies , 1993, Neurology.

[27]  B T Hyman,et al.  Kunitz Protease Inhibitor‐Containing Amyloid β Protein Precursor Immunoreactivity in Alzheimer's Disease , 1992, Journal of neuropathology and experimental neurology.

[28]  R. Katzman.,et al.  Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.

[29]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[30]  C. Duyckaerts,et al.  Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person , 1990, Neuroscience Letters.

[31]  A. Lees,et al.  A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.

[32]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[33]  E. Masliah,et al.  Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies , 1991, Neuroscience Letters.